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Abstract
Objective: To devise a set of clinical signs and laboratory parameters that would help clinicians assess
prognosis in patients and plan appropriate management.
Methods: Medical records of 147 paediatric cases (with a discharge diagnosis of acute viral
encephalitis) admitted over a ten year period from 1987 to 1997 were reviewed and relevant
information collected on a data extraction form.
Results: Of 147 patients, 24 (16.3%) died and 48 (32.7%) were left with severe neurological deficits. A
GCS (Glasgow Coma Scale) score between 6-10 had an association with poor outcome (OR = 2.62,
Chi-square = 5.57, p-value = 0.018) and that a GCS score of >5 was even more strongly suggestive of
poor outcome (OR = 5.49, Chisquare = 12.08, p-value =0.0005). A history of having seizures, for more
than 3 days, also showed a strong association with poor outcome (OR= 3.66, Chi- square = 5.46, pvalue = 0.019).
Conclusion: Patients with an increased risk of death and severe disability can be identified using a few
guidelines. Of these, a history of seizures of >3 days and/or impaired consciousness (GCS _10), at the
time of presentation to the hospital, constitute high risk. These cases must be identified promptly and
aggressive therapy initiated in order to improve long term outcome OPMA 49:311,1999).
Introduction
Central Nervous System (CNS) infections have tremendous importance because of their potential for
death and permanent neurological damage. The reported incidence of acute encephalitis is between 3.57.5 cases per 100,000 patient years1. In children the incidence is about 16.7 cases per 100,000 patient
years2. Acute encephalitis occurs most commonly in the first decade of life with a peak incidence of 12 cases per 1000 in the first 6 months of life 3. The mortality rate of children with acute encephalitis is
3.8- 28.0%4. Study done in American paediatric population, showed that 40% of children who
recovered from acute encephalitis had persistent non-progressive neurological abnormalities5. Several
studies have been done to find clinical parameters that could predict poor outcome, one such study
done in U.K. showed clinical predictors as young age at presentation, alow score on the Glasgow Coma
Scale (GCS), disruption of the occulocephalic response and laboratory evidence of infection in the
CNS6. In a study on 462 Finnish children4, the risk of death or severe damage in children less than one
year of age was five-fold greater than that of older children. There was a 3.9% greater risk of death or
severe damage in those children who had been disoriented on admission versus those who were not. In
addition those children with Herpes Simplex Virus (HSV) or Mycoplasma pneumoniae type
encephalitis had greater risk (11.7 fold and 7 fold respectively) of death or severe damage versus those
of other viral aetiologies. In another paediatric study focal neurological signs and abnormal
neuroimaging studies were the only two factors that predicted poor short-term outcome7. The GCS was
only predictive if profoundly depressed (<6) but was otherwise not useful.
The impact of acute viral encephalitis on individuals and families can be devastating. As timely
intervention can be life saving, the aim of this study was to determine the clinical signs and laboratory

parameters that could help assess high risk cases of viral encephalitis in our local setting.
Patients and Methods
The study was conducted at The Aga Khan University Hospital (AKUH), Karachi. A retrospective
review of records was performed using a pre-tested data extraction form. We included all paediatric
cases aged <15 years, admitted during the 10 years between 1987-1997, who presented within one
month of symptom onset and had a diagnosis at discharge of viral encephalitis 4. For the ten years
period of observation, a final study population of 147 was reached.
The data extraction form was constructed based on criteria laid out by Western literature4-7, a study
conducted in India8 as well as in-house neurologists. It collected relevant information on
demographics, signs and symptoms at presentation, laboratory and radiological investigations done,
treatment given and outcome recorded (both at discharge and at follow up within 6 months).
Outcome was expressed in four categories which ranked from 1-4 as follows: 1 = death, 2 = major
neurological sequelae, 3 = minor neurological sequelae, 4 complete recovery with no deficits. Major
sequelae included seizures, frank motor deficits (increased tone, hemiplegias, monoplegias, cerebellar
signs, lower motor neuron signs, extrapyramidal signs), cranial nerve damage, mental retardation8.
Minor sequelae were scholastic backwardness, subtle neurological signs (up-going plantars, incoordinate or brisk reflexes) and behavioural changes8. For the purpose of analysis death and major
sequelae were regrouped as ‘poor outcome’ whereas minor sequelae and recovery were called
‘favourable outcome’. EPI Info version 6.0 statistical package was used for data analysis. Poor
outcome (n=72) was compared with favourable outcome (n=75) in terms of clinical variables like
symptoms, signs, laboratory values, radiology and treatment at admission. Age was grouped into
discrete categories (il, 2-5, 6-10 and 11-15 years), as was duration of symptoms (<3, 4-7 and >7 days )
and GCS (<5, 6-10 and 11-15). All other values were grouped as abnormal or normal based on hospital
set protocol. Chi-square analysis was used to determine presence of association and odds ratio
calculated for significant results. Results were considered significant if p-value was <0.05.
Results
A total of 147 cases fullfilled our case definition, of these 42 (28.8%) were females and 104 (71.2%)
male. No age group dominated. Acute encephalitis was not associated with any particular season. The
most common symptoms at presentation were fever in 114 (77.5%), impaired consciousness in 83
(56.5%) and seizures in 81(55.1%) cases. Sixty-nine (52.3%) had a GCS of 11-15 at presentation
(Table 1).

Documentation of physical signs were missing in many files and highly variable in the remaining ones;
therefore these could not be assessed.
None of the haematological investigations revealed any significant trend (Table 2).

Serum sodium was normal in 72.5% cases. Cerebrospinal fluid (CSF) examination was not done in 29
(19.7%) cases. In the remaining cases CSF analysis revealed abnormal leukocyte counts in 40.7%.
Lymphocytosis was found in 82.6% cases in which a CSF Differential Leukocyte count (DLC) was
performed. Sixty percent of CSF protein levels fell within the normal range as did CSF glucose levels
(60% cases). Of the cases in which CSF culture and sensitivity was performed, 98% showed no growth.
Electroencephalogram (EEG) was performed in 89 cases of which 86 (96.6%) had abnormal findings
and CT scan was performed in 83 cases, of which 45 (54.2%) showed abnormalities. Acyclovir was
administered in 39 patients (27%). Mean hospital stay was of 9.3 days, with 82 (55.8%) staying for a
week or less and 125 (85%) being discharged within two weeks (Table 1).
Of 147 cases, 24 (16.3%) died. For the remainder at discharge, 48 (32.7%) had major sequelae, 19
(12.9%) had minor sequelae and 56 (38.1%) recovered completely. Of the major sequelae seen, the
commonest was motor deficits in 26 followed by seizures in 14 . The more common minor sequelae
seen at discharge were subtle neurological defects in 11 and behavioural changes in 3. Of those who
died, 5 (20.8%) had complicating systemic diagnoses but this was not statistically significant. Follow
up records were not available for 62 (50.4%) cases. In those who came for follow up, major sequelae
were found in 16 (26.2%) patients and minor sequelae in 13 (2 1.3%) patients (Table 3).

For ease of analysis we combined the groups death and major sequelae as poor outcome and minor
sequelae and complete recovery as favourable outcome. No significant association of outcome was
found with age at presentation (Chi-square = 3.99, p-value = 0.26) or season at presentation (Chisquare = 1.00, p-value = 0.80). A GCS score of 6-10 was significantly associated with poor outcome
(OR=2.64, Chi-square=5 .57, p-value=0.0 182). There was a significantly worsening prognosis as GCS
fell below 5 (OR = 5.49, Chi-square = 12.08, p-value = 0.0005) and the Chi-square for this linear trend
was significant (p-value 0.00025). Of the presenting symptoms, a history of seizures for >7 days,
although showing a strong association with poor outcome (one-tailed Fisher exact p-value = 0.011),
failed to generate an Odds ratio due to the fact that no patient presenting with such a prolonged
duration had a favourable outcome. To overcome this the duration of symptoms were regrouped into
two categories of <3 and >3 days and the Odds ratio recalculated. The result then showed that a history
of seizures of >3 days duration suggested poor outcome (OR = 3.66, Chisquare=5.46, p-value = 0.0 19)
(Table 4).

Hyponatremia was not found to have any relation with outcome (OR=1.10, Chi square=0.06, pvalue=0.81), neither did CSF lymphocytosis (OR=5.09, Chi-square=2.49, p-value=0.115) nor CSF
protein (OR=l.39, Chi-square=0.55, p-value=0.46). Despite the fact that EEG abnormalities were
present in 96.6% tested cases, no significant association with outcome could be established (one-tailed
Fisher exact p-value=0.086). CT abnormalities also failed to show an association with outcome
(OR=1.09, Chi-square=0.04, pO.846) (Table 4). The administration of acyclovir did not affect outcome
(OR=0.86, Chi square0.17, p=0.68) (Table 4).
Of the patients who did have a follow up record in their file, a strong association was found between
poor status at discharge and poor status at follow up (0R72.00, Chi-square=29.63, p

Discussion
In this study we have taken viral encephalitis caused by infection with any one of several common
viruses as one entity. Although this does not take into account the pathogenesis of individual etiological
agents this study has the advantage of being applicable in our setting where sophisticated investigations
for causative organisms are not carried out.
Previous studies have shown conflicting views regarding the age at presentation and outcome. Our
finding was that age at presentation had no relation with the prognosis. This is in accordance with Klein
et al.7 but differs from Rautonen et al.4 and Kennedy et al. 6 who found a significantly worse prognosis
in those aged <3 and <1 years respectively. Seasonal variation has been seen to have a relation with the
onset of viral encephalitis, being more in winter and early spring in the west and following the
monsoon season in Lucknow, India8. However, no such correlation was found in this study, but this
could be due to the absence of well-defined seasons in this part of the sub-continent.
The most common clinical presentations were fever, impaired consciousness, seizures, vomiting,
behavioural changes, recent rash and a recent history seizures of respiratory infections. Out of these,
history of with an onset of greater than 3 days, showed an association with poor outcome. Rautonen et
al.4 correlated the duration of symptoms with outcome in their study among Finnish children but were
unable to get results that were statistically significant.
One of the most important findings in this study was that those patients with a score of<5 on the
Glasgow Coma Scale had a significantly worse prognosis than those with a higher score. This is in
accordance with previous studies, especially those of Kennedy et al.6 and Klein et al.7 We, however,
also showed that the prognosis was poor even for a relatively higher score of 6-10 and as GCS fell
below this the prognosis deteriorated concurrently. Abnormal occulocephalic reflexes have a very
strong correlation with unfavourable outcome6. Unfortunately due to lack of adequate documentation
we were unable to assess this parameter. Previous studies have contemplated the relationship between
CSF findings and outcome. However no significant associations have been established which is in
agreement with our findings.
Two other diagnostic modalities analysed were the CT and the EEG. Magnetic Resonance Imaging
(MRI) has only been recently introduced at our hospital and therefore this investigation was excluded
from our analysis. EEG picked up abnormalities in 97% cases compared with CT which picked up
abnormalities in 54% (Table 2). In both these cases, however, no statistically significant association
with outcome could be established.
The antiviral drug Acyclovir is used in Herpes Simplex Virus (HSV) encephalitis and if administered
early drastically improves the course of this potentially fatal illness. In our analysis Acyclovir
administration had no relation with outcome. However, the role of this drug cannot be assessed from
this finding as we did not stratify for HSV.
At the time of discharge 49% of patients either died or had major sequelae. This is in contrast with
Rautonen et al. 4 in which 9.5% of cases died or had severe damage. This discrepancy could be
explained by differences in race, etiological agent, the duration of the illness at which the patient
presented and the inability of the family to afford tertiary care resulting in the patient being discharged
once stabilised (not cured) i.e., before optimum therapy. The latter limitation would make the patient
appear worse off than those admitted for a longer period. To overcome this bias it would have been
ideal to have documentation of a follow up visit. Unfortunately follow up records were not available
for half of the cases. However it was seen that in those with a follow up there was a significant
correlation with poor status at discharge and subsequent follow up. Similarly those with a favourable
outcome on discharge maintained a good status on follow up.
We conclude that increased rate of death and severe damage in encephalitis can be identified by a few
basic factors. Specific attention should be focused on those cases that present with a history of seizures

of >3 days duration prior to admission and especially those which have presented with impaired
consciousness. Being a pilot study we recommend that more research should be directed towards viral
encephalitis and other acute central nervous system infections.
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